GranuFlo is one of the most common dry acid products prescribed for kidney dialysis. Patients receiving the GranuFlo product suffered severe cardiac complications resulting in significant injury and, in some cases, death. Recently, the Plaintiffs Steering Committee and the Attorneys for Fresenius, the manufacturer of Granfulo, reached an agreement to settle these cases for $250 million.
In these cases, as with all medical device and pharmaceutical cases, the settlement process requires a comprehensive medical and scientific evaluation of medical records. Our team of nurse-paralegals and medical doctors work together to create medical record claims packages and comprehensive reports outlining key events and estimated settlement values.
At Physicians Medical Review, our team of in-house physicians provides full-service support for pharmaceutical litigation, which includes:
According to the FDA, GranuFlo carries serious health risks such as:
We can connect you with our team of highly qualified and credentialed medical experts to assist you with all aspects of your GranuFlo claim. We provide all the medical support you need to facilitate the efficient settlement of your case.
Find out more about our litigation and settlement support when you contact Physicians Medical Review at (888) 391-6998.
At Physican's Medical Review we can satistify all your medical legal consulting needs.